일리노이의 궤양성 대장염 임상 시험
궤양성 대장염 관련 연구 23개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.
일리노이의 도시
공식 연구 텍스트(영어)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-005, Des Plaines
- Site US-007, Glenview
- Site US-020, Gurnee
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07845487A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Illinois Gastroenterology Group - Gurnee, Gurnee
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06636656LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
- Midwest Digestive Health & Nutrition, Des Plaines
- 외 1개
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07415044A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Rush University Medical Center, Chicago
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07483073Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Rush University Medical Center, Chicago
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Center for Gastrointestinal Health - Fairview Heights, Belleville
- Northwestern University, Chicago
- Midtown Gastroenterology and Liver Disease, Des Plaines
- 외 2개
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07186101A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Yapp, Rockford M.D. (Private Practice), Downers Grove
- GI Alliance - Glenview, Glenview
- Gastroenterology and Internal Medicine Specialists, SC, Lake Barrington
- 외 3개
피험자 모집 중4상
18세 ~ 80세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06581328A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- University of Chicago Medical Center, Chicago
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06979336Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Midwest Digestive Health & Nutrition /ID# 285250, Des Plaines
- Gi Alliance - Glenview /ID# 283932, Glenview
- Illinois Gastroenterology Group /ID# 283933, Gurnee
- 외 1개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07697456A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- University of Chicago Medical Center, Chicago
피험자 모집 중2상
12세 ~ 17세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT05287126A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 038, Chicago
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07012395A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University of Chicago Medical Center /ID# 271588, Chicago
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07071519An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
- Suburban Gastroenterology Ltd, Naperville
피험자 모집 중관찰 연구
18세 ~ 64세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06398626Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Northwestern Medicine Lake Forest Hospital, Lake Forest
피험자 모집 중
18세 ~ 85세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT05987852An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Rush University Medical Center - Site Number: 8400015, Chicago
- Midwest Digestive Health and Nutrition - Site Number: 8400136, Des Plaines
- GI Alliance - Glenview - Site Number: 8400068, Glenview
- 외 1개
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07184996A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0101, Park Ridge
피험자 모집 중2/3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT05076175STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
- University of Chicago, Chicago
피험자 모집 중
18세 ~ 75세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT06693310A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Gurnee-Site Number:, Gurnee
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT07185009A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Advocate Children's Hospital Park Ridge, Park Ridge
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06405087Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Chicago Medicine, Chicago
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT05230173Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
- Northwestern University, Chicago
피험자 모집 중2상
18세 ~ 85세 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT07427017A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Advocate Children's Hospital - Park Ridge - PIN, Park Ridge
피험자 모집 중3상
2세 이상 · 모든 성별 · 2026. 5. 7. 업데이트됨 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Glenview
- Mirador Therapeutics Selected Site, Gurnee
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT07113522ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.